News summarySeeking AlphaNov 11, 2026, 11:02 AM
MaxCyte outlines at least $34.5M 2026 revenue as it plans Akron Bio deal to accelerate profitability
MaxCyte outlines at least $34.5M 2026 revenue as it plans Akron Bio deal to accelerate profitability(摘要待生成)